Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT

Bone Marrow Transplantation

Volumn 43, Issue 12, 2009, Pages 969-970

  Fuchs, E J ^a   Luznik, L ^a   Bolanos Meade J ^a   Miller, C B ^b   Brodsky, R A ^a   Ambinder, R F ^a   Jones, R J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b St Agnes Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; ESTRADIOL; FOLLITROPIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMENORRHEA; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILDBIRTH; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FEMALE; FEMALE INFERTILITY; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MENSTRUAL CYCLE; MONOTHERAPY; MYELOABLATIVE CONDITIONING; NODULAR SCLEROSIS HODGKIN LYMPHOMA; OVARIAN PRESERVATION; OVARY FUNCTION; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REPRODUCTION; SPLENECTOMY;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HODGKIN DISEASE; HUMANS; INFANT, NEWBORN; LYMPHOMA, FOLLICULAR; PREGNANCY; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 67649883198     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.416     Document Type: Letter

References (11)

1. Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS et al Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: Report from the bone marrow transplant survivor study. Bone Marrow Transplant 2006; 37: 1023-1029.
2. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001; 358: 271-276.
3. Giralt S, Estey E, Albitar M, Van Besien K, Rondon G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531-4536.
4. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
5. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in olderpatients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
6. Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation forhematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641-650.
7. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancies following high-dose cyclophosphamide with orwithout high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
8. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K et al Ovarian function following marrow transplantation foraplastic anemia orleukemia. J Clin Oncol 1988; 6: 813-818.
9. Liu J, Malhotra R, Voltarelli J, Stracieri AB, Oliveira L, Simoes BP et al. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant 2007; 41: 275-278.
10. Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D et al. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: An analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26: 455-462.
11. Rezvani AR, Storer B, Maris M, Sorror ML, Agura E, Maziarz RT et al Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. J Clin Oncol 2008; 26: 211-217.